Combined gemcitabine and alpha-interferon therapy for pancreatic cancer: report of a case.
Sawai
Hirozumi
H
Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan, 4678601. cb8h-swi@asahi-net.or.jp
Okada
Yuji
Y
Tanaka
Moritsugu
M
Funahashi
Hitoshi
H
Yamamoto
Minoru
M
Takeyama
Hiromitsu
H
Manabe
Tadao
T
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D017809:Fatal Outcome; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D016898:Interferon-alpha; D003841:Deoxycytidine; D000093542:Gemcitabine